Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals
Nicolás A. Muena, Tamara García‐Salum, Catalina Pardo‐Roa, et al.
EBioMedicine (2022) Vol. 78, pp. 103972-103972
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 59
Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination
Xiaogang Tong, R. P. McNamara, María José Avendaño, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort
Amy Nouanesengsy, Anthony Semesi, Kim Ưng Quách, et al.
Microbiology Spectrum (2025)
Open Access
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Hadeel T. Zedan, Hadi M. Yassine, Duaa W. Al‐Sadeq, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
Marina Saresella, Federica Piancone, Ivana Marventano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital
Vidya Arankalle, A. G. Kulkarni, Ruta Kulkarni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 180-180
Open Access | Times Cited: 3
Investigating the Seroconversion Patterns of Specific Antibodies Against Various Antigens of SARS-CoV-2 in Hospitalized COVID-19 Patients and Vaccinated Individuals
Shahrzad Matinfar, Sahar Mortezagholi, darya amiri, et al.
Archives of Clinical Infectious Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac
Ho Yu Ng, Yunshi Liao, Ruiqi Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2583-2583
Open Access | Times Cited: 2
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Andrea Carolina Machado-Sulbarán, et al.
Immunology Letters (2022) Vol. 251-252, pp. 20-28
Open Access | Times Cited: 12
Adipokines, and not vitamin D, associate with antibody immune responses following dual BNT162b2 vaccination within individuals younger than 60 years
Mariana Pavel, Daniela Constantinescu, Corina Cianga, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
Why It Remains Statistically Probable That SARS-CoV-2 Was Isolated and Then Accidentally Lab-Leaked before the First COVID-19 Outbreak
Theodor-Nicolae Carp
(2024)
Open Access | Times Cited: 1
Why It Remains Statistically Probable That SARS-CoV-2 Was Isolated and Then Accidentally Lab-Leaked before the First COVID-19 Outbreak
Theodor-Nicolae Carp
(2024)
Open Access | Times Cited: 1
Which test results to believe? Comparison of different ELISA kits for detection of SARS-CoV-2-neutralizing antibody among COVID-vaccinated individuals
Uday Yanamandra, Kundan Tandel, Karthik Rayapureddi, et al.
Medical Journal Armed Forces India (2024)
Closed Access | Times Cited: 1
Effectiveness of CoronaVac versus BNT162b2 based on neutralizing antibody response: A systematic review
Zeynep Ece Kuloğlu, Şiran Keske, Mert Ahmet Kuşkucu, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 621-624
Closed Access | Times Cited: 1
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers
Narayanaiah Cheedarla, Hans Verkerke, Sindhu Potlapalli, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108256-108256
Open Access | Times Cited: 4
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
Ximena Aguilera, Juan Hormazábal, Cecilia Vial, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1051-1051
Open Access | Times Cited: 7
Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines
Roberta Mancuso, Simone Agostini, Lorenzo Agostino Citterio, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1649-1649
Open Access | Times Cited: 7
Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
Cheng Siang Tan, Vaenessa Noni, Whilemena Upam Herman Ulok Melina, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Receptor‐binding domain‐based SARS‐CoV‐2 vaccine adjuvanted with cyclic di‐adenosine monophosphate enhances humoral and cellular immunity in mice
María José Germanó, Constanza Giai, Diego Esteban Cargnelutti, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 3
Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening
Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents
Hao Wang, Yuan Yu, Bihao Wu, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 4, pp. 747-757
Open Access | Times Cited: 2
Metabolic Adaptations Correlated with Antibody Response after Immunization with Inactivated SARS-CoV-2 in Brazilian Subjects
Jeane de Souza Nogueira, Cíntia Barros Santos-Rebouças, Rafael Mina Piergiorge, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 6, pp. 1908-1922
Closed Access | Times Cited: 2
COVID-19 Infection, Vaccination, and Antibody Levels: Investigating Correlations through a Cohort Study
Gözde Akkuş Kayalı, Seyfi Durmaz, İrem Şahin, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1258-1258
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top